ArticleEuropean radiology2025
Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Are AI Neuroimaging Models Ready for Clinical Use? A Systematic Methodological Review.Journal of clinical medicine · 2026Review
- Super-resolution and habitat radiomics based computed tomography machine-learning model for prediction of lung invasive adenocarcinoma: a multi-centre study.Quantitative imaging in medicine and surgery · 2026Article
- Graphical and interactive spatial proteomics image analysis workflow.GigaByte (Hong Kong, China) · 2026Article
- Impact of ComBat harmonization on MRI radiomic-analysis of nasopharyngeal carcinoma: a dual-center study.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo assess the effect of different intensity standardisation techniques (ISTs) and ComBat batch sizes on radiomics survival model performance and stability in a heterogenous, multi-centre cohort of patients with glioblastoma (GBM).
methodsMulti-centre pre-operative MRI acquired between 2014 and 2020 in patients with IDH-wildtype unifocal WHO grade 4 GBM were retrospectively evaluated. WhiteStripe (WS), Nyul histogram matching (HM), and Z-score (ZS) ISTs were applied before radiomic feature (RF) extraction. RFs were realigned using ComBat and minimum batch size (MBS) of 5, 10, or 15 patients. Cox proportional hazards models for overall survival (OS) prediction were produced using five different selection strategies and the impact of IST and MBS was evaluated using bootstrapping. Calibration, discrimination, relative explained variation, and model fit were assessed. Instability was evaluated using 95% confidence intervals (95% CIs), feature selection frequency and calibration curves across the bootstrap resamples.
resultsOne hundred ninety-five patients were included. Median OS = 13 (95% CI: 12-14) months. Twelve to fourteen unique MRI protocols were used per MRI sequence. HM and WS produced the highest relative increase in model discrimination, explained variation and model fit but IST choice did not greatly impact on stability, nor calibration. Larger ComBat batches improved discrimination, model fit, and explained variation but higher MBS (reduced sample size) reduced stability (across all performance metrics) and reduced calibration accuracy.
conclusionHeterogenous, real-world GBM data poses a challenge to the reproducibility of radiomics. ComBat generally improved model performance as MBS increased but reduced stability and calibration. HM and WS tended to improve model performance. KEY POINTS: Question ComBat harmonisation of RFs and intensity standardisation of MRI have not been thoroughly evaluated in multicentre, heterogeneous GBM data. Findings The addition of ComBat and ISTs can improve discrimination, relative model fit, and explained variance but degrades the calibration and stability of survival models. Clinical relevance Radiomics risk prediction models in real-world, multicentre contexts could be improved by ComBat and ISTs, however, this degrades calibration and prediction stability and this must be thoroughly investigated before patients can be accurately separated into different risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.